Maravai LifeSciences Holdings, Inc. MRVI Debt Repayments
Debt Repayments at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s debt repayments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s debt repayments?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported debt repayments of $51.36M in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s debt repayments changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s debt repayments increased by 3676.5% year-over-year, from $1.36M to $51.36M.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s debt repayments?
- Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s debt repayments has grown at a -2.4% compound annual growth rate (CAGR), from $6M to $5.44M.
- What does debt repayments mean?
- Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.